Statement by the OECD/NEA Steering Committee for Nuclear Energy Regarding Policy Actions Necessary to Ensure the Long-term Security of Supply of Medical Radioisotopes
Joint Declaration on the Security of Supply of Medical Radioisotopes
Déclaration du Comité de direction de l’énergie nucléaire de l’OCDE/AEN sur les mesures à prendre pour favoriser la sécurité d’approvisionnement à long terme en radioisotopes à usage médical
Déclaration commune sur la sécurité d'approvisionnement en radioisotopes à usage médical
Current status and future actions to ensure the reliable supply for molybdenum-99 (99Mo), and a conversation on a new generation of innovative radioisotopes for diagnostics and therapy
The NEA hosted...
NEA and CNIC announced plans for collaborative efforts to help ensure the supply of medical radioisotopes.
At the request of its member countries, the NEA became involved in global efforts to ensure an economically sustainable secure supply of molybdenum-99/technetium-99m. This final concluding report of ...
This report includes information provided confidentially by supply chain participants to support this new work of the NEA, which follows previous work undertaken by the High-level Group on the Securi...
The NEA established the High-level Group on the Security of Supply of Medical Radioisotopes (HLG-MR) in April 2009 to examine the underlying reasons for the global 2009-10 supply shortage and to deve...
This workbook has been developed to aid reactor and alternative technology operators identify their full costs associated with the provision of irradiation services for 99Mo production. The workbook ...
This document provides guidance to reactor and alternative production technology (e.g., cyclotrons, accelerators) operators on how to undertake full-cost identification and implement full-cost recove...
Technetium‑99m (Tc‑99m) is the most commonly used radioisotope in nuclear medicine diagnostic scans. It is essential for diagnostic scans of a broad range of body parts, and thus for accurate diagnos...